US · Healthcare

ManifestSeven Holdings Corporation (MNFSF)

Drug Manufacturers - Specialty & Generic

ManifestSeven Holdings Corporation (MNFSF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MNFSF

P/E ratio

18.00

ManifestSeven Holdings Corporation (MNFSF) — FAQ

What is MNFSF's P/E ratio?

The price-to-earnings (P/E) ratio for ManifestSeven Holdings Corporation (MNFSF) is 18.00 (data as of 2026-03-24).

Does ManifestSeven Holdings Corporation pay a dividend?

Dividend yield is not available in the current snapshot for ManifestSeven Holdings Corporation (MNFSF). Check the MyAverix Finance app for the latest dividend data.

What sector is ManifestSeven Holdings Corporation in?

ManifestSeven Holdings Corporation (MNFSF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is MNFSF listed on?

MNFSF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)